The next stage in the pathway to medtech regulatory reform in Great Britain is expected in May, when the Medicines and Healthcare products Regulatory Agency (MHRA) will publish the government’s response to the late 2024 public consultation.
Medtech Regulatory System, IDAP And CERSI Top UK MHRA Agenda In March Update
Incoming MHRA Chair Gives Debt Of Thanks To Departing CEO June Raine
Britain’s medtech system progress, smarter ways of working at the agency and getting smarter AI and digital technologies into circulation for patients, were themes woven through the UK MHRA board’s 18 March meeting.
More from Regulation
• By
Pediatric devices and IVDs are to be a priority. And the European Health Data Space regulation is seen as critical in supporting digital technologies and AI in transforming care.
• By
As deadlines approach, the regulatory landscape for medtech batteries is set to change, with an emphasis on sustainability and ethical practices.
The Doctor Patient Forum says the US FDA should regulate a scoring platform from Bamboo Health intended to help clinicians calculate risk for opioid abuse as a medical device to ensure patient safety.
• By
EU medtech trade associations present detailed arguments for the European Commission’s 'targeted evaluation' of medtech regulations, highlighting the need for immediate course correction.